Minocycline and Ifenprodil Prevent Development of Painful Diabetic Neuropathy in Streptozotocin-induced Diabetic Rat Model

Authors

  • Che Aishah Nazariah Ismail BRAINetwork Centre for Neurocognitive Sciences, School of Health Sciences, Department of Physiology, School of Medical Science, Universiti Sains Malaysia Heath Campus, 16150 Kubang Kerian, Kelantan, Malaysia
  • Suppian Rapeah School of Health Sciences Universiti Sains Malaysia Heath Campus, 16150 Kubang Kerian, Kelantan, Malaysia
  • Abd Aziz Che Badariah Department of Physiology, School of Medical Science, Universiti Sains Malaysia Heath Campus, 16150 Kubang Kerian, Kelantan, Malaysia
  • Long Idris BRAINetwork Centre for Neurocognitive Sciences, School of Health Sciences, School of Health Sciences Universiti Sains Malaysia Heath Campus, 16150 Kubang Kerian, Kelantan, Malaysia

Keywords:

Painful diabetic neuropathy, minocycline, ifenprodil, formalin test, catalase, interleukin-1β, malondialdehyde, superoxide dismutase, tumour necrosis factor-α

Abstract

Painful diabetic neuropathy (PDN) is a common complication of diabetes mellitus which hugely affect life routines and quality. We aimed to investigate the effects of minocycline and ifenprodil on nociceptive behavior response, oxidant-antioxidant status and pro-inflammatory markers level in the PDN rat’s spinal cord. Forty-eight male Sprague-Dawley rats were divided into six groups (n=8): non-diabetic control, diabetic PDN control, diabetic PDN rats received minocycline (80μg/day or 160μg/day) and diabetic PDN rats received ifenprodil (0.5μg/day or 1.0μg/day). Diabetes was induced by single injection of streptozotocin at 60mg/kg. The rats were allowed for two weeks period to develop into PDN condition. The intrathecal treatments were given for seven days period. The rat’s hind paw was then injected with 5% formalin to induce chronic inflammatory pain and sacrificed three days post-formalin injection. Spinal cord tissue was removed and homogenized (10% homogenate). ELISA for oxidant-antioxidant markers (MDA, catalase and SOD) and pro-inflammatory markers (TNF-α and IL-1β) were carried out. The results showed that untreated PDN rats exhibited increased nociceptive behavior responses indicating hyperalgesia apart from increased MDA activity, reduced catalase with insignificant change in SOD enzymes activities, increased TNF-α and insignificant change in IL-1β level. Minocycline and ifenprodil suppressed MDA activity and improved catalase and SOD activities. Minocycline attenuated both pro-inflammatory cytokines whilst ifenprodil reduced TNF-α level but increased IL-1β level. In conclusion, minocycline and ifenprodil showed potent anti-nociceptive, anti-oxidant and anti-inflammatory effects but possibly via different pathway and mechanism.

Downloads

Download data is not yet available.

References

Aras M, Urfali B, Serarslan Y, Özgur T, Ulutas KT, Urfali S, Altas M and Yilmaz N (2013) Protective effects of minocycline against short-term ischemia-reperfusion injury in rat brain. Pediatric Neurosurgery, 49(3): 172-178.

Ates O, Cayli SR, Yucel N, Altinoz E, Kocak A, Durak MA, Turkoz Y and Yologlu S (2007) Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats. Journal of Clinical Neuroscience, 14(3): 256-260.

Ates O, Yucel N, Cayli SR, Altonoz E, Yologlu S, Kocak A, Cakir CO and Turkoz Y (2006) Neuroprotective effect of etomidate in the central nervous system of streptozotocin-induced diabetic rats. Neurochemical Research, 31(6): 777-783.

Boyce S, Wyatt A, Webb J, O’Donnell R, Mason G, Rigby M, Sirinathsinghji D, Hill R and Rupniak N (1999) Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology, 38(5): 611-623.

Chizh BA, Reibmuller E, Schlutz H, Scheede M, Haase G and Englberger W (2001) Supraspinal vs spinal sites of the antinociceptive action of the subtype-selective NMDA antagonist ifenprodil. Neuropharmacology, 40(2): 212-220.

Daulhac L, Mallet C, Courteix C, Etienne M, Duroux E, Privat AM, Eschalier A and Fialp J (2006) Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-D-aspartate-dependent mechanisms. Molecular Pharmacology, 70(4): 1246-1254.

Dean OM, Data-Franco J, Giorlando F and Berk M (2012) Minocycline. CNS Drugs, 26(5): 391-401.

Delibas N, Kilinc I, Yonden Z, Sutcu R, Gultekin F, and Koylu H (2004) NMDA receptor subunits 2A and 2B decrease and lipid peroxidation increase in the hippocampus of streptozotocin-diabetic rats: effects of insulin and gliclazide treatments. International Journal of Neuroscience, 114(3): 391-401.

Dubuisson D and Dennis SG (1978) The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain, 4: 161-174.

El-Khatib AS, Moustafa AM, Abdel Aziz AAH, Al-Shabanah OA and El-Kashef HA (2001) Effects of aminoguanidine and desferrioxamine on some vascular and biochemical changes associated with streptozotocin-induced hyperglycaemia in rats. Pharmacological Research, 43(3): 233-240.

Fu KY, Light AR, Matsushima GK and Maixner W (1999) Microglial reactions after subcutaneous formalin injection into the rat hind paw. Brain Research, 825(1): 59-67.

Gilgun-Sherki Y, Rosenbaum Z, Melamed E and Offen D (2002) Antioxidant therapy in acute central nervous system injury: current state. Pharmacological Reviews, 54(2): 271-284.

Hayati AA, Zalina I, Myo T, Badariah A, Azhar A and Idris L (2008) Modulation of formalin-induced fos-like immunoreactivity in the spinal cord by swim stress-induced analgesia, morphine and ketamine. Ger Med Sci, 6(6): Doc05.

Hu XL, Gao LY, Niu YX, Tian X, Wang J, meng WH, Zhaong Q, Cui C, Han L and Zhao QC (2015) Neuroprotection by Kukoamine A against oxidative stress may involve N-methyl-d-aspartate receptors. Biochimica et Biophysica Acta (BBA)-General Subjects, 1850(2): 287-298.

Jang YY, Song JH, Shin YK, Han ES and Lee CS (2000) Protective effect of boldine on oxidative mitochondrial damage in streptozotocin-induced diabetic rats. Pharmacological Research, 42(4): 361-371.

Jirmanova I (1993) Giant axonopathy in streptozotocin diabetes of rats. Acta Neuropathologica, 86(1): 42-48.

Kedziora-Kornatowska KZ, Luciak M, Blaszczyk J and Pawlak W (1998) Effect of Aminoguanidine on Erythrocyte Lipid Peroxiclation and Activities of Antioxidant Enzymes in Experimental Diabetes, Clinical Chemistry and Laboratory Medicine, 36(10):771-775.

Kline KM, Caroll DG and Malnar KF (2003) Painful diabetic peripheral neuropathy relieved with use of oral topiramate. Southern Medical Journal, 96(6): 602-605.

Kobayashi K, Imagama S, Ohgomori T, Hirano K, Uchimura K, Sakamoto K, Hirakawa A, Takeuchi H, Suzumura A and Ishigaro N (2013) Minocycline selectively inhibits M1 polarization of microglia. Cell Death & Disease, 4(3): e525.

Koneri RB, Samaddar S, Simi SM and Rao ST (2014) Neuroprotective effect of a triterpenoid saponin isolated from Momordica cymbalaria Fenzl in diabetic peripheral neuropathy. Indian Journal of Pharmacology, 46(1): 76-81.

Krady JK, Basu A, Allen CM, Xu Y, Lanoue KF, Gardner TW and Levison SW (2005) Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes, 54(5): 1559-1565.

Kraus RL, Pasieczny R, Lariosa-Willingham K, Turner MS, Jiang A and Trauger JW (2005) Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. Journal of Neurochemistry, 94(3): 819-827.

Kriz J, Gowing G and Julien JP (2003) Efficient three-drug cocktail for disease induced by mutant superoxide dismutase. Annals of Neurology, 53(4): 429-436.

Leung L and Cahill CM (2010) TNF-α and neuropathic pain - a review. Journal of Neuroinflammation, 7(27): 1-11.

Lu R and Schmidtko A (2013) Direct intrathecal drug delivery in mice for detecting in vivo effects of cGMP on pain processing. Guanylate Cyclase and Cyclic GMP. 1020: 215-221.

Ma QP and Hargreaves R (2000) Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats. Neuroscience, 101(3): 699-707.

Marchand F, Tsantoulas C, Singh D, Grist J, Clark AK, Bradbury EJ and McMahon SB (2009) Effects of Etanercept and Minocycline in a rat model of spinal cord injury. European Journal of Pain, 13(7): 673-681.

Miyachi Y, Yoshioko A, Imamura S and Niwa Y (1986) Effect of antibiotics on the generation of reactive oxygen species. Journal of Investigative Dermatology, 86(4): 449-453.

Mohan IK and Das U (1998). Effect of l-arginine–nitric oxide system on chemical-induced diabetes mellitus. Free Radical Biology and Medicine, 25(7): 757-765.

Montilla PL, Vargas JF, Tunez IF, Carmen M, Agueda M, Valdelvira M and Cabrera ES (1998) Oxidative stress in diabetic rats induced by streptozotocin: protective effects of melatonin. Journal of Pineal Research, 25(2): 94-100.

Mora M, Bonilla E, Median-Leendertz S, Bravo Y and Arcaya JL (2014) Minocycline increases the activity of superoxide dismutase and reduces the concentration of nitric oxide, hydrogen peroxide and mitochondrial malondialdehyde in manganese treated Drosophila melanogaster. Neurochemical Research, 39(7): 1270-1278.

Noguchi K (2010) IL-18-mediated microglia/astrocyte interaction in the spinal cor and neuropathic pain. European Journal of Pain Supplements, 4(1): 4.

Obrosova IG, Fathallah L and Greene DA (2000) Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: effect of DL-α-lipoic acid. European Journal of Pharmacology, 398(1): 139-146.

Pabreja K, Dua K, Sharma S, Padi SS and Kulkarni SK (2011) Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms. European Journal of Pharmacology, 661(1): 15-21.

Qujeq D, Aliakbarpour HR and Kalavi K (2004) Relationship between malondialdehyde level and glutathione peroxidase activity in diabetic rats. Clinica Chimica Acta, 340(1): 79-83.

Raghavendra V, Tanga F and Deleo JA (2003) Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. Journal of Pharmacology and Experimental Therapeutics, 306(2): 624-630.

Saini AK, Hs AK and Sharma SS (2007) Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy. European Journal of Pharmacology, 568(1): 164-172.

Sandireddy R, Yerra VG, Areti A, Komirishetty P and Kumar A (2014) Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets. International Journal of Endocrinology, 2014(2014): 1-10.

Skundric DS and Lisak RP (2003) Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration. Journal of Diabetes Research, 4(4): 303-312.

Stirling DP, Koochesfahani KM, Steeves JD and Tetzlaff W (2005) Minocycline as a neuroprotective agent. The Neuroscientist, 11(4): 308-322.Sun JS, Yang YJ, Zhang YZ, Huang W, Li ZS and Zhang Y (2015) Minocycline attenuates pain by inhibiting spinal microglia activation in diabetic rats. Molecular Medicine Reports, 12(2): 2677-2682.

Suzuki T, Kato H, Tsuda M, Suzuki H and Misawa M (1999) Effects of the non-competitive NMDA receptor antagonist ifenprodil on the morphine-induced place preference in mice. Life Sciences, 64(12): PL151-PL156.

Tangpong J, Sompol P, Vore M, Clair WS, Butterfield D and Clair DS (2008) Tumor necrosis factor alpha–mediated nitric oxide production enhances manganese superoxide dismutase nitration and mitochondrial dysfunction in primary neurons: an insight into the role of glial cells. Neuroscience, 151(2): 622-629.

Tavakoli M and Malik Ra (2008) Management of painful diabetic neuropathy. Expert Opinion on Pharmacotherapy, 9(17): 2969-2978.

Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V and Vinik A (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care, 33(10): 2285-2293.

Tikka T, Fiebich BL, Goldsteins G, Keinanen R and Koistinaho J (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. Journal of Neuroscience, 21(8): 2580-2588.

Tikka TM and Koistinaho JE (2001) Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. The Journal of Immunology, 166(12): 7527-7533.

Tsuda M (2016) Microglia in the spinal cord and neuropathic pain. Journal of Diabetes Investigation, 7(1): 17-26.

Tsuda M, Ueno H, Kataoka A, Tozaki-Saitoh H and Inoue K (2008) Activation of dorsal horn microglia contributes to diabetes-induced tactile allodynia via extracellular signal-regulated protein kinase signaling. Glia, 56(4): 378-386.

Van Dam PS, Van Asbeck BS, Bravenboer B, Van Oirschot JF, Gispen WH and Marx JJ (1998) Nerve function and oxidative stress in diabetic and vitamin E-deficient rats. Free Radical Biology and Medicine, 24(1): 18-26.

Vela JM, Molina-Holgado E, Arevalo-Martin Á, Almazan G and Guaza C (2002) Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Molecular and Cellular Neuroscience, 20(3): 489-502.

Wang D, Couture R and Hong Y (2014) Activated microglia in the spinal cord underlies diabetic neuropathic pain. European Journal of Pharmacology, 728(5): 59-66.

Wang W, Mei XP, Wei YY, Zhang MM, Zhang T, Wang W, Xu LX, Wu SX, and Li YQ (2011) Neuronal NR2B-containing NMDA receptor mediates spinal astrocytic c-Jun N-terminal kinase activation in a rat model of neuropathic pain. Brain, Behavior, and Immunity, 25(7): 1355-1366.

Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T and Koistinaho J (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proceedings of the National Academy of Sciences, 95(26): 15769-15774.

Zhang W, Shi CX, Gu XP, Ma ZL and Zhu W (2009) Ifenprodil induced antinociception and decreased the expression of NR2B subunits in the dorsal horn after chronic dorsal root ganglia compression in rats. Anesthesia & Analgesia, 108(3): 1015-1020.

Zhao WC, Zhang B, Liao MJ, Zhang WX, He WY, Wang HB and Yang CX (2014) Curcumin ameliorated diabetic neuropathy partially by inhibition of NADPH oxidase mediating oxidative stress in the spinal cord. Neuroscience Letters, 560: 81-85.

Zhu X, Dong J, Shen K, Bai Y, Zhang Y, Lv X, Chao J and Yao H (2015) NMDA receptor NR2B subunits contribute to PTZ-kindling-induced hippocampal astrocytosis and oxidative stress. Brain Research Bulletin, 114: 70-78.

http://www.ijlsci.in/volume-6-issue-1-march-2018

Downloads

Published

2018-02-24

How to Cite

Che Aishah Nazariah Ismail, Suppian Rapeah, Abd Aziz Che Badariah, & Long Idris. (2018). Minocycline and Ifenprodil Prevent Development of Painful Diabetic Neuropathy in Streptozotocin-induced Diabetic Rat Model. International Journal of Life Sciences, 6(1), 29–40. Retrieved from https://ijlsci.in/ls/index.php/home/article/view/1430

Issue

Vol. 6 No. 1 (2018): International Journal of Life Sciences

Section

Research Articles

License

Copyright (c) 2018 Authors

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license unless indicated otherwise in a credit line to the material. If the material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/